Literature DB >> 17581610

JAK2-V617F activating mutation in acute myeloid leukemia: prognostic impact and association with other molecular markers.

C Vicente, I Vázquez, N Marcotegui, A Conchillo, C Carranza, G Rivell, E Bandrés, I Cristobal, I Lahortiga, M J Calasanz, M D Odero.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17581610     DOI： 10.1038/sj.leu.2404812

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  8 in total

1.  A JAK2-V617F activating mutation in addition to KIT and FLT3 mutations is associated with clinical outcome in patients with t(8;21)(q22;q22) acute myeloid leukemia.

Authors:  Eisaku Iwanaga; Tomoko Nanri; Naofumi Matsuno; Toshiro Kawakita; Hiroaki Mitsuya; Norio Asou
Journal:  Haematologica       Date:  2009-01-30       Impact factor: 9.941

Review 2.  Genetics of donor cell leukemia in acute myelogenous leukemia and myelodysplastic syndrome.

Authors:  Lacey Williams; Kimberley Doucette; Judith E Karp; Catherine Lai
Journal:  Bone Marrow Transplant       Date:  2021-03-08       Impact factor: 5.483

Review 3.  Targeting novel signaling pathways for resistant acute myeloid leukemia.

Authors:  Kathleen M Sakamoto; Steven Grant; Diana Saleiro; John D Crispino; Nobuko Hijiya; Francis Giles; Leonidas Platanias; Elizabeth A Eklund
Journal:  Mol Genet Metab       Date:  2014-12-05       Impact factor: 4.797

4.  JAK2 V617F mutation in myelodysplastic syndrome, myelodysplastic syndrome/myeloproliferative neoplasm, unclassifiable, refractory anemia with ring sideroblasts with thrombocytosis, and acute myeloid leukemia.

Authors:  Dong Wook Jekarl; Sang Bong Han; Myungshin Kim; Jihyang Lim; Eun-Jee Oh; Yonggoo Kim; Hee-Je Kim; Woo-Sung Min; Kyungja Han
Journal:  Korean J Hematol       Date:  2010-03-31

Review 5.  Master regulatory GATA transcription factors: mechanistic principles and emerging links to hematologic malignancies.

Authors:  Emery H Bresnick; Koichi R Katsumura; Hsiang-Ying Lee; Kirby D Johnson; Archibald S Perkins
Journal:  Nucleic Acids Res       Date:  2012-04-05       Impact factor: 16.971

6.  DNLC: differential network local consistency analysis.

Authors:  Jianwei Lu; Yao Lu; Yusheng Ding; Qingyang Xiao; Linqing Liu; Qingpo Cai; Yunchuan Kong; Yun Bai; Tianwei Yu
Journal:  BMC Bioinformatics       Date:  2019-12-24       Impact factor: 3.169

7.  Inactivation of Receptor Tyrosine Kinases Reverts Aberrant DNA Methylation in Acute Myeloid Leukemia.

Authors:  Na Shen; Fei Yan; Jiuxia Pang; Na Zhao; Naseema Gangat; Laichu Wu; Ann M Bode; Aref Al-Kali; Mark R Litzow; Shujun Liu
Journal:  Clin Cancer Res       Date:  2017-07-18       Impact factor: 12.531

8.  Secondary Acute Myeloid Leukemia in a One-Year-Old Girl Diagnosed with JAK2-V617F Mutation Positive Myeloproliferative Neoplasm.

Authors:  Gary M Woods; Rajinder P S Bajwa; Samir B Kahwash; Terri Guinipero
Journal:  Case Rep Med       Date:  2014-03-18
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.